UCHL1 and neoplasm: Focusing on targeted and non-targeted DECs of hematological tumor patients and non-tumor individuals (Fig. 3E; Table S2), we found that targeted DECs (e.g., PRRX1-UCHL1 complex and CEN complex) were usually enriched with functions/pathways such as ubiquitin and cell cycle (Fig. 3E).